Opko Health, Inc.

305 articles about Opko Health, Inc.

• JPM17: Opko Health CEO's Gameplan After Its Recent Growth Hormone Failure

  1/13/2017

• Phase III Flop for Pfizer's Drug Partner Opko Health

  1/3/2017

• Opko Health Appoints Dr. Benjamin Solomon As Managing Director Of GeneDx

  9/27/2016

• Opko Health To Present Long-Acting Human Growth Hormone (HGH-CTP) Phase II Pediatric Growth Hormone Deficiency Data At The 55th Annual Meeting Of The European Society For Pediatric Endocrinology

  9/6/2016

• Opko HealthTo Participate In Upcoming September Conferences

  9/2/2016

• Opko Health Completes Acquisition Of Transition Therapeutics

  8/31/2016

• Transition Therapeutics Shareholders Approve Acquisition by Opko Health

  8/26/2016

• Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval Of The Plan Of Arrangement With Opko Health

  8/26/2016

• Opko Health Responds To Law Firm Notice Of Investigation

  8/23/2016

• Opko Health Reports Improved Financial and Operating Results

  8/9/2016

• Opko Health To Announce Second Quarter Operating And Financial Results On August 8, 2016

  8/3/2016

• Opko Health to Acquire Transition Therapeutics in $60M Deal

  6/30/2016

• Opko Health Rockets on FDA Approval of Rayaldee Four Months Ahead of PDUFA Date

  6/22/2016

• Opko Health To Host Analyst & Investor Day In New York City On June 15

  6/15/2016

• Opko Health Announces Move To NASDAQ Stock Market

  6/13/2016

• Opko Health To Discuss Draft Coverage Determinations For 4Kscore Test At 2016 Jefferies Healthcare Conference

  6/8/2016

• Opko Health To Present At The 2016 Jefferies Healthcare Conference

  6/2/2016

• Opko Health Receives Proposed/Draft Medicare Local Coverage Determination For 4KScore Test

  5/27/2016

• 3 Life Science Stocks Short-Sellers are Wrong About

  5/20/2016

• Opko Health Announces Appointment Of Douglass Laidlaw As Vice President Of Medical Affairs

  5/11/2016